(Q71073079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Thrombolysis with prourokinase versus urokinase: an in vitro comparison (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

D Fox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

K Ouriel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R M Green

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Stoughton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

P Riggs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C Cimino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 April 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

Journal of Vascular Surgery

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

657-666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

Surgical treatment versus thrombolysis in acute arterial occlusion: a randomised controlled study

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Selective Clot Lysis with Low-Dose Streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Therapeutic Alternatives for Subacute Peripheral Arterial Occlusion Comparison by Outcome, Length of Stay, and Hospital Charges

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Relative Cost-Effectiveness of Urokinase versus Streptokinase in the Treatment of Peripheral Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Acute peripheral arterial and graft occlusion: treatment with selective infusion of urokinase and lysyl plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

1 reference

7 January 2021

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Thrombolytic effect of single-chain pro-urokinase in a rabbit jugular vein thrombosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Coronary thrombolysis in dogs with intravenously administered human pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Plasminogen acceleration of urokinase thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Clot-selective coronary thrombolysis with pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

The rabbit as a model for studies of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2896%2980047-4

7 January 2021

10.1016/S0741-5214(96)80047-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627903%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference